Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMissing a week of Mounjaro is more common than people expect, and it does not mean your treatment has failed. If your next scheduled dose is more than four days away, the standard clinical guidance is to take the missed dose as soon as you remember, then return to your usual weekly day. If fewer than four days remain before your next scheduled injection, skip the missed dose and continue as normal. That four-day rule is drawn from the Mounjaro Patient Information Leaflet and the NHS tirzepatide guidance; it exists to keep your doses spaced safely apart. Mounjaro is a prescription-only medicine, and any questions specific to your own situation should be directed to your prescriber rather than answered by a general guide alone.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
When you realise you've missed a weekly injection, the first question isn't "have I ruined everything", it's a simple time check. Count the days between now and your next scheduled dose. If that gap is more than four days, go ahead and take the dose you missed. Your normal weekly rhythm then continues from that point, not from the original day.
If you're within four days of the next planned injection, leave the missed dose and inject on schedule as usual. Taking both pens in quick succession would compress two doses into a short window, raising the chance of nausea and other gastrointestinal side effects without any therapeutic benefit. The Mounjaro treatment overview explains how the weekly schedule is designed to keep blood levels steady, compressing it works against that design.
One practical detail worth knowing: tirzepatide's pharmacological half-life is roughly five days. That means a week after your last pen, a meaningful portion of the medicine is still present in your system. If you're wondering whether missing a week of Mounjaro is ever genuinely safe, the short answer is that one missed injection is not the same as stopping treatment. Progress rarely reverses in a single week.
Appetite is the thing most people notice first. Mounjaro works partly by slowing gastric emptying and signalling fullness, so as levels dip, hunger can creep back in a way that felt unfamiliar after weeks on treatment. Some people also find cravings more noticeable. This is a physiological response, not a sign that the medicine was ever going to stop working for you.
It helps to treat that window the same way you'd approach any other hungry day: lean on protein, stay hydrated, and don't mistake returning appetite for a reversal of your progress. A single missed week is unlikely to produce meaningful weight regain. If you're finding missed doses are happening regularly, that's a conversation worth having with your prescriber, not because it signals failure, but because there may be practical or clinical reasons worth exploring. You can reach our team through the contact page any day of the week.
People feel genuinely anxious when a pen goes missing or a week slips by, that anxiety is understandable, and it usually says more about how much the treatment matters to you than about any real clinical risk from one missed dose.
Occasional missed injections happen; life gets in the way. But if weeks are being skipped repeatedly, it's worth pausing to understand why. Sometimes it's practical, a pen was out of stock, travel disrupted the cold chain, or the weekly habit hasn't solidified. Sometimes it reflects side effects that are making people reluctant to inject. Both are solvable with the right clinical input.
The NICE appraisal of tirzepatide (TA1026) sets out that treatment effectiveness is reviewed at six months; consistent use across that window is what the clinical evidence is built on. Irregular dosing isn't accounted for in trial data, which means the results that inform prescribing decisions (around 20% average weight reduction in SURMOUNT-1 at the highest dose) reflect participants who took their weekly injection reliably.
If supply or cost is part of the picture, it's worth understanding what a full private treatment plan actually includes before concluding that gaps are unavoidable. The Mounjaro cost guide covers what's included in a transparent private prescription and what to look for when comparing providers.
For a broader look at whether a break of more than one week changes the clinical picture, the two-week missed dose page goes into more detail on longer gaps. And if you're still weighing up whether skipping a single injection is ever genuinely acceptable, this related page addresses that question directly.
After one missed week, most people simply continue at their current dose on their next scheduled day, no adjustment needed. After a longer break, the clinical picture is different. A gap of several weeks may mean the prescriber wants to step the dose back temporarily to avoid the tolerability issues that the careful escalation schedule was designed to prevent in the first place.
That escalation (starting at 2.5mg to let the body adjust, then stepping up every four weeks) exists for a reason. The starter dose's job is tolerance, not weight loss. Reintroducing a higher dose after a meaningful gap without that buffer can sharpen gastrointestinal side effects noticeably. Your prescriber is the right person to make that call, not a general guide.
At nume, sorry, at our pharmacy, every repeat order is reviewed individually by a GPhC-registered prescriber before it's approved. There are no automated renewals. If you've had a gap, that review is a natural moment to flag it and get tailored advice. For a full picture of how missed doses fit into ongoing treatment, the missing a week of Mounjaro page covers the wider context, and our FAQs address many of the practical questions that come up around dose timing. If you'd like a clinical conversation, start your free consultation and a prescriber will review your situation the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.